Cantel’s general counsel to retire; successor named

Little Falls-based Cantel Medical Corp. announced Wednesday that Eric Nodiff, executive vice president, general counsel and secretary, will be retiring on July 31. Nodiff is retiring after spending 32 years with the company.

Cantel also announced Jeff Mann will succeed Nodiff, naming him senior vice president, general counsel and secretary, effective Aug. 1.

Mann, who joined Cantel in 2018 as vice president, deputy general counsel, will now be tasked with overseeing all legal matters impacting the company, including general corporate matters, mergers and acquisitions, corporate governance and Securities and Exchange Commission compliance.

Prior to Cantel, he held leadership roles at Boston Scientific Corp. He has more than 19 years of experience in law, including leadership on mergers and acquisitions, intellectual property, securities, corporate governance, commercial transactions and litigation.

“On behalf of the board, we are pleased to appoint Jeff to his new role. Since joining Cantel as vice president, deputy general counsel last year, Jeff successfully supported the growth of our business while evaluating potential risk and maintaining careful governance to ensure that all aspects of the Company are compliant with relevant laws, policies and regulations,” George Fotiades, CEO and president, said. “Jeff is a values-driven leader who has an impressive track record and demonstrated strong leadership skills over the past year by providing strategic counsel on a wide range of legal matters, helping to ensure that Cantel is best equipped to meet our business objectives. I am confident that Jeff is the right choice to take on this critical role and we wish him every success.”